Effect of Bovine α1 Interferon on Bovine Herpesvirus Type 1-induced Respiratory Disease

References

1. Arvin A., Yeager A., Merigan T. C. 1976; Effect of leukocyte interferon on urinary excretion of cytomegalovirus by infants. Journal of Infectious Diseases 133: (Supplement) A205–A210
   [Google Scholar]
2. Babiuk L. A., Acres S. D. 1984; Models for bovine respiratory disease. In Bovine Respiratory Disease: A Symposium pp 287–325 Edited by Loan R. W. College Station: Texas A & M University Press;
   [Google Scholar]
3. Babiuk L. A., Rouse B. T. 1976; Immune interferon production by lymphoid cells: role in the inhibition of herpesviruses. Infection and Immunity 13:1567–1578
   [Google Scholar]
4. Babiuk L. A., Rouse B. T. 1978; Interactions between effector cell activity and lymphokines: implications for the recovery from herpesvirus infections. International Archives of Allergy and Applied Immunology 57:62–73
   [Google Scholar]
5. Babiuk L. A., Wardley R. C., Rouse B. T. 1975; Defense mechanisms against bovine herpesviruses: relationship of virus-host cell events to susceptibility to antibody complement cell lysis. Infection and Immunity 12:958–963
   [Google Scholar]
6. Baker P. E., Knoblock K. F. 1982a; Bovine costimulator. I. Production kinetics, partial purification and quantification in serum free Iscoves medium. Veterinary Immunology and Immunopathology 3:365–379
   [Google Scholar]
7. Baker P. E., Knoblock K. F. 1982b; Bovine costimulator. II. Generation and maintenance of a bovine costimulator-dependent bovine lymphoblastoid cell line. Veterinary Immunology and Immunopathology 3:381–397
   [Google Scholar]
8. Bielefeldt Ohmann H., Babiuk L. A. 1984a; Effect of bovine recombinant alpha interferon on inflammatory responses of bovine phagocytes. Journal of Interferon Research 4:249–263
   [Google Scholar]
9. Bielefeldt Ohmann H., Babiuk L. A. 1984b; In vitro generation of hydrogen peroxide and of superoxide anion by bovine polymorphonuclear neutrophilic granulocytes, blood monocytes, and alveolar macrophages. Inflammation 8:251–275
   [Google Scholar]
10. Bielefeldt Ohmann H., Babiuk L. A. 1985; Viral-bacterial pneumonia in calves: effect ofbovine herpes virus-1 on immunological functions. Journal of Infectious Diseases 151:937–947
    [Google Scholar]
11. Bielefeldt Ohmann H., Gilchrist J. E., Babiuk L. A. 1984; Effect of recombinant DNA-produced bovine interferon alpha (BoIFN-α, ) on the interaction between bovine alveolar macrophages and bovine herpesvirus type 1. Journal of General Viology 65:1487–1495
    [Google Scholar]
12. Brunda M. J., Rosenbaum D. 1984; Modulation of murine natural killer cell activity in vitro and in vivo by recombinant human interferons. Cancer Research 44:547–601
    [Google Scholar]
13. Cesario T. C. 1983; The clinical implications of human interferon. Medical Clinics of North America 67:1147–1162
    [Google Scholar]
14. Cheeseman S., Rubin R., Stewart J., Tolkoff-Rubin N. E., Cosimi A. B., Cantell K., Gilbert J., Winkle S., Herrin J. T., Black R. H., Russel P. S., Hirsch M. S. 1979; Controlled clinical trial of prophylactic human-leukocyte interferon in renal transplantation. New England Journal of Medicine 300:1345–1349
    [Google Scholar]
15. Cummins J. M., Rosenquist B. D. 1980; Protection of calves against rhinovirus infection by nasal secretions interferon induced by infectious bovine rhinotracheitis. American Journal of Veterinary Research 41:161–165
    [Google Scholar]
16. De Clercq E., De Somer P. 1968; Protective effect of interferon and polyacrylic acid in newborn mice infected with a lethal dose of vesicular stomatitis virus. Life Sciences 7:925–930
    [Google Scholar]
17. Demaeyer E., Demaeyer-Guignard J. 1982; Immunomodulating properties of interferons. Philosophical Transactions of the Royal Society B299:77–90
    [Google Scholar]
18. Desmyter J., Ray M., De Groute J., Bradburne A. F., Desmet V. J., Edy V. G., Billiau A., De Somer P. 1976; Administration of human fibroblast interferon in chronic hepatitis B virus infections. Lancet 11:645–647
    [Google Scholar]
19. Douglas R., Betts R. 1974; Effect of induced interferon in experimental rhinovirus infections in volunteers. Infection and Immunity 9:506–510
    [Google Scholar]
20. Dziewanowska Z. E., Pestka S. 1982; The human interferons. Medical Research Reviews 2:325–353
    [Google Scholar]
21. Emodi G., O’Reilly R., Muller A., Everson L. K., Binswanger W., Just M. 1976; Effect of human exogenous leukocyte interferon in cytomegalovirus infections. Journal of Infectious Diseases 133: (Suuplement) A199–A204
    [Google Scholar]
22. Fauconnier B. 1971; Effect of anti-interferon serum on experimental viral pathogenicity in vivo. Pathologic Biologic 19:575–578
    [Google Scholar]
23. Filion L. O., McGuire R. L., Babiuk L. A. 1983; Nonspecific suppressive effect of bovine herpesvirus type 1 on bovine leukocyte functions. Infection and Immunity 42:106–112
    [Google Scholar]
24. Garry F. B. 1984; Plasma fibrinogen measurement: prognostic value in calf bronchopneumonia. l Zentralblattflir Veterinarmedizin A31:361–369
    [Google Scholar]
25. Gresser I. 1977; Commentary: on the varied biological effects of interferon. Cellular Immunology 34:406–415
    [Google Scholar]
26. Gresser I., Coppey J., Brouty-Boye D., Falcoff R., Falcoff E., Zajdela F. 1976a; Interferon and murine leukaemia. III. Efficacy of interferon preparations administered after inoculation of Friend virus. Nature, London 215:174–175
    [Google Scholar]
27. Gresser I., Tovey M., Maury C., Bandu M. T. 1976b; Role of interferon in the pathogenesis of virus diseases in mice as demonstrated by the use of anti-interferon serum. II. Studies with herpes simplex, Moloney sarcoma, vesicular stomatitis, Newcastle disease, and influenza viruses. Journal of Experimental Medicine 144:1316–1327
    [Google Scholar]
28. Herberman R. B., Ortaldo J. R., Mantovani A., Hobbs D. S., Rung H. F., Pestka S. 1982; Effect of human recombinant interferon in cytotoxic activity of natural killer (NK) cells and monocytes. Cellular Immunology 67:160–167
    [Google Scholar]
29. Isaacs A., Lindenmann J. 1957; Virus interference. I. The interferon. Proceedings of the Royal Society B147:258–267
    [Google Scholar]
30. Jakab G. J. 1984; Viral bacterial interactions in respiratory tract infections: a review of the mechanisms of virus induced suppression of pulmonary antibacterial defenses. In Bovine Respiratory Diseases: A Symposium pp 223–286 Edited by Loan R. W. College Station: Texas A & M University Press;
    [Google Scholar]
31. Johnson H. M., Baron S. 1976; Interferon: effects on the immune response and the mechanism of activation of the cellular response. CRC Critical Reviews of Biochemistry 4:203–227
    [Google Scholar]
32. Johnson H., Smith B., Baron S. 1975; Inhibition of the primary in vitro antibody response by interferon preparations. Journal of Immunology 114:403–409
    [Google Scholar]
33. Jones B., Coster D., Falcon M., Cantell K. 1976; Topical therapy of ulcerative herpetic keratitis with human interferon. Lancer ii:128–1976
    [Google Scholar]
34. Larsson A., Forsgren M., Hard S. 1976; Administration of interferon to an infant with congenital rubella syndrome involving persistent viremia and cutaneous vasculitis. Acta paediatrica 65:105–110
    [Google Scholar]
35. Leung D. W., Capon D. J., Goeddel D. V. 1984; The structure and bacterial expression of three distinct bovine genes. Biotechnology 2:458–464
    [Google Scholar]
36. Merigan T. C. 1982; Interferon therapy of human viral infections and malignant disease. Annals of Internal Medicine 96:80–93
    [Google Scholar]
37. Merigan T., Waddell D., Grossman M. 1968; Modified skin lesions during concurrent varicella and measles. Journal of the American Medical Association 240:333–347
    [Google Scholar]
38. Merigan T. C., Reed S., Hall T., Tyrrell D. A. J. 1973; Inhibition of respiratory virus infection by topically applied interferon. Lancet 1:563–567
    [Google Scholar]
39. Merigan T. C., Rand K., Pollard R., Abdallah A. S., Jordan G. W., Fried R. P. 1978; Human leukocyte interferon for the treatment of herpes zoster in patients with cancer. New England Journal of Medicine 298:981–987
    [Google Scholar]
40. Nakamura M., Manser T., Pearson G. D. N., Daley M. J., Geffer M. L. 1984; Effect of IFN On the immune response in vivo and on gene expression in vitro. Nature, London 307:381–382
    [Google Scholar]
41. Panusarn C., Stanley E., Dirda V., Rubenis M., Jackson G. G. 1974; Prevention of illness from rhinovirus infection by a topical interferon inducer. New England Journal of Medicine 291:57–61
    [Google Scholar]
42. Riviere Y., Gresser I., Guillon J., Tovey M. G. 1977; Inhibition by anti-interferon serum of lymphocytic choriomeningitis virus disease in suckling mice. Proceedings of the National Academy of Sciences, U. S. A 74:2135–2139
    [Google Scholar]
43. Rosenquist B. D. 1984; Viruses as etiological agents of bovine respiratory disease. In Bovine Respiratory Disease: A Symposium pp 363–376 Edited by Loan R. W. College Station: Texas A & M University Press;
    [Google Scholar]
44. Scott G. M., Wallace J., Greiner J., Phillpotts P. J., Gauci C. L., Tyrrell D. A. J. 1982; Prevention of rhinovirus colds by human interferon alpha-2 from Escherichia coli. Lancet 11:186–188
    [Google Scholar]
45. SehgaL P. B. 1982; The interferon genes. Biochimica et biophysica acta 695:17–33
    [Google Scholar]
46. Senik A., Gresser L., Maury C., Gidlund M., Orn A., Wigzell H. 1979; Enhancement by interferon of natural killer cell activity in mice cell. Immunology 55:186–193
    [Google Scholar]
47. Shalaby M. R., Weck P. K., Rinkerknecht E., Harkins R. N., Frane J. W., Ross M. J. 1984; Effects of bacteria-produced human alpha, beta and gamma interferons on in vitro immune functions. Cellular Immunology 84:380–392
    [Google Scholar]
48. Slauson D. O. 1982; The mediation of pulmonary inflammatory injury. Advances in Veterinary Science and Comparative Medicine 26:99–153
    [Google Scholar]
49. Thomson R. G., Chander S., Savan M., Fox M. L. 1975; Investigation of factors of probable significance in the pathogenesis of pneumonic pasteurellosis in cattle. Canadian Journal of Comparative Medicine 39:194–207
    [Google Scholar]
50. Todd J. D., Volence F. J., Paton I. M. 1972; Interferon in nasal secretions and sera of calves after intranasal administration of avirulent infectious bovine rhinotracheitis virus: association of interferon in nasal secretions with early resistance to challenge with virulent virus. Infection and Immunity 5:699–706
    [Google Scholar]
51. Yates W. D. G., Babiuk L. A., Jericho K. W. F. 1982; Viral-bacterial pneumonia in calves: duration of the interaction between bovine herpesvirus-1 and Pasteurella haemolvtica. Canadian Journal of Comparative Medicine 47:257–264
    [Google Scholar]